Get started
Author

Jian‐Yong Ding

Observed names: Ding, Jian-Yong, J. Ding, J.-Y. Ding, JIANYONG DING, Jian-Yong Ding, Jian-yong Ding, JianYong Ding, Jianyong Ding, Jian‑Yong Ding
Observed institutions: Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center, Zhongshan Hospital, Guangdong Academy of Medical Sciences, Obstetrics and Gynecology Hospital of Fudan University, Guangdong Provincial People's Hospital, Zhejiang Taizhou Hospital, Sysmex (Japan), Southern Medical University
ORCID: 0000-0003-2729-3141
Observed ORCID: 0000-0003-2729-3141
OpenAlex ID: A5012765559
Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
2019 · J. Gao, H.-R. Li, et al. · Clinical & Translational Oncology · 112
USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma
2014 · Guang-Yin Zhao, Zong-Wu Lin, et al. · Tumor Biology · 84
PDF
Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer
2013 · Jie Gu, Jian-yong Ding, et al. · Lung Cancer · 80
Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1
2022 · Jian Gao, Yong-Qiang Ao, et al. · Journal of Experimental & Clinical Cancer Research · 78
High level of BRD4 promotes non-small cell lung cancer progression
2016 · Yun-Fei Liao, Yong-Bing Wu, et al. · Oncotarget · 61
PDF
The overexpression of 14‐3‐3ζ and Hsp27 promotes non–small cell lung cancer progression
2013 · Guang‐Yin Zhao, Jian‐Yong Ding, et al. · Cancer · 52
FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5
2010 · Y. Huang, H. Jin, et al. · Endocrine Related Cancer · 52
PDF
Immunotherapy of thymic epithelial tumors: molecular understandings and clinical perspectives
2023 · Yong-Qiang Ao, Jian Gao, et al. · Molecular Cancer · 42
PDF
CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells
2018 · Lin Wang, Lin Shi, et al. · Journal of Physiology and Biochemistry · 41
Low level of 5-Hydroxymethylcytosine predicts poor prognosis in non-small cell lung cancer
2016 · YUNFEI LIAO, JIE GU, et al. · Oncology Letters · 33
PDF
ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3
2023 · Yong-Qiang Ao, Jian Gao, et al. · Journal for ImmunoTherapy of Cancer · 31
PDF
Ring finger protein 38 promote non-small cell lung cancer progression by endowing cell EMT phenotype
2018 · Dian Xiong, Shu-Qiang Zhu, et al. · Journal of Cancer · 31
PDF
Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village
2023 · Yong-Qiang Ao, Jian Gao, et al. · Molecular Therapy · 29
Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2
2015 · Jie Gu, Feng-kai Xu, et al. · Medical Oncology · 29
Tumor-infiltrating CD36+CD8+T cells determine exhausted tumor microenvironment and correlate with inferior response to chemotherapy in non-small cell lung cancer
2023 · Yong-Qiang Ao, Jian Gao, et al. · BMC Cancer · 26
PDF
Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression
2016 · Wei Jiang, Hong Fan, et al. · BMC Cancer · 26
PDF
Elevated circASCC3 limits antitumor immunity by sponging miR-432–5p to upregulate C5a in non-small cell lung cancer
2022 · Jian Gao, Ling-Xian Zhang, et al. · Cancer Letters · 24
PDF
CXCR4 heterogeneous expression in esophageal squamous cell cancer and stronger metastatic potential with CXCR4-positive cancer cells
2013 · C.-L. Lu, J. Guo, et al. · Diseases of the Esophagus · 24
Elevated FUS/TLS expression is negatively associated with E‑cadherin expression and prognosis of patients with non‑small cell lung cancer
2018 · Dian Xiong, Yong‑Bing Wu, et al. · Oncology Letters · 22
PDF
An Optimal mRNA Marker for OSNA (One-step Nucleic Acid Amplification) Based Lymph Node Metastasis Detection in Colorectal Cancer Patients
2013 · N. Yamamoto, M. Daito, et al. · Japanese Journal of Clinical Oncology · 21
Benefits of multi‐disciplinary treatment strategy on survival of patients with colorectal cancer liver metastasis
2020 · Yang Lv, Qing‐Yang Feng, et al. · Clinical and Translational Medicine · 20
Perioperative Safety and Efficacy of Efgartigimod for Thymoma-Associated Myasthenia Gravis: A Prospective, Multicenter, Phase II Clinical Trial
2025 · Shuai Wang, Min Zhu, et al. · Journal of Thoracic Oncology · 17
Circulating tumor cell methylation profiles reveal the classification and evolution of non-small cell lung cancer
2022 · Jia-Hao Jiang, Jian Gao, et al. · Translational Lung Cancer Research · 17
PDF
Downregulation of SETBP1 promoted non-small cell lung cancer progression by inducing cellular EMT and disordered immune status.
2020 · Hao-Ran Li, Jian Gao, et al. · PubMed Central · 17
Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study
2016 · Qingyang Feng, Ye Wei, et al. · Oncotarget · 17
PDF
Works count: 41
Citation count: 1,019
H-index: 20
I10-index: 26
Year
Topic
Type